2019 | (18)F-flortaucipir uptake patterns in clinical subtypes of primary progressive aphasia | NEUROBIOLOGY OF AGING |
2015 | [(18)F] FP-CIT PET study in parkinsonian patients with leukoaraiosis | PARKINSONISM & RELATED DISORDERS |
2015 | [(18)F]FPEB and [(18)F]FDEGPECO comparative study of mGlu5 quantification in rodent brain | APPLIED RADIATION AND ISOTOPES |
2017 | 18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome | NEUROLOGY |
2017 | 18F-AV-1451 Binds to Putamen in Multiple System Atrophy | MOVEMENT DISORDERS |
2017 | 18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy | JOURNAL OF ALZHEIMERS DISEASE |
2015 | 18F-Mefway PET imaging of serotonin 1A receptors in humans: a comparison with 18F-FCWAY
| PLOS ONE |
2014 | A Computed Tomography-Based Spatial Normalization for the Analysis of [18F] Fluorodeoxyglucose Positron Emission Tomography of the Brain
| KOREAN JOURNAL OF RADIOLOGY |
2021 | Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging | JAMA NEUROLOGY |
2020 | Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2023 | Assessing the applicability of PMOD residence times model for PET image-based radiation dosimetry
| SCIENTIFIC REPORTS |
2020 | Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease | JAMA NEUROLOGY |
2018 | Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging | JAMA NEUROLOGY |
2023 | Association of Sleep Disturbances With Brain Amyloid and Tau Burden, Cortical Atrophy, and Cognitive Dysfunction Across the AD Continuum | NEUROLOGY |
2016 | Biodistribution and Radiation Dosimetry of [18F]Mefway in Humans | MOLECULAR IMAGING AND BIOLOGY |
2011 | Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson's disease | JOURNAL OF NEUROLOGY |
2010 | Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment | EUROPEAN NEUROLOGY |
2021 | Combined Model of Aggregation and Network Diffusion Recapitulates Alzheimer's Regional Tau-Positron Emission Tomography | BRAIN CONNECTIVITY |
2020 | Customized FreeSurfer-based brain atlas for diffeomorphic anatomical registration through exponentiated lie algebra tool | ANNALS OF NUCLEAR MEDICINE |
2018 | Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders | JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION |
2018 | Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases | MOVEMENT DISORDERS |
2020 | Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease
| ALZHEIMERS & DEMENTIA |
2014 | Dopaminergic neuron destruction reduces hippocampal serotonin 1A receptor uptake of trans-[F]Mefway | APPLIED RADIATION AND ISOTOPES |
2022 | Dynamic network model reveals distinct tau spreading patterns in early- and late-onset Alzheimer disease
| ALZHEIMERS RESEARCH & THERAPY |
2020 | Effect of A/T/N imaging biomarkers on impaired odor identification in Alzheimer's disease
| SCIENTIFIC REPORTS |
2020 | Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease
| ALZHEIMERS RESEARCH & THERAPY |
2008 | Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
| BRAIN |
2017 | Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease | NEUROBIOLOGY OF AGING |
2015 | Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image
| PLOS ONE |
2018 | Head to head comparison of [(18)F] AV-1451 and [(18)F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2016 | Human Radiation Dosimetry of [(18)F]AV-1451(T807) to Detect Tau Pathology | MOLECULAR IMAGING AND BIOLOGY |
2016 | In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum | ANNALS OF NEUROLOGY |
2018 | Increased Uptake of AV-1451 in a Subacute Infarction Lesion
| YONSEI MEDICAL JOURNAL |
2021 | MRI-Visible Perivascular Spaces in the Centrum Semiovale Are Associated with Brain Amyloid Deposition in Patients with Alzheimer Disease-Related Cognitive Impairment | AMERICAN JOURNAL OF NEURORADIOLOGY |
2023 | Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease | EUROPEAN JOURNAL OF NEUROLOGY |
2018 | Off-Target (18)F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation | JOURNAL OF NUCLEAR MEDICINE |
2016 | Optimal timing of [18F]Mefway PET for imaging the serotonin 1A receptor in healthy male subjects | APPLIED RADIATION AND ISOTOPES |
2016 | P-Glycoprotein, not BCRP, Limits the Brain Uptake of [(18)F]Mefway in Rodent Brain | MOLECULAR IMAGING AND BIOLOGY |
2018 | Predicted sequence of cortical tau and amyloid-beta deposition in Alzheimer disease spectrum | NEUROBIOLOGY OF AGING |
2018 | Predominant subcortical accumulation of (18)F-flortaucipir binding in behavioral variant frontotemporal dementia | NEUROBIOLOGY OF AGING |
2020 | Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer's disease
| ALZHEIMERS RESEARCH & THERAPY |
2019 | Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study | JOURNAL OF NUCLEAR MEDICINE |
2015 | Relationship between dopamine deficit and the expression of depressive behavior resulted from alteration of serotonin system | SYNAPSE |
2008 | Relationship between the striatal and cerebellar glucose metabolism and the response to levodopa treatment in patients with multiple system atrophy | JOURNAL OF MOVEMENT DISORDERS |
2023 | Role of Enlarged Perivascular Space in the Temporal Lobe in Cerebral Amyloidosis | ANNALS OF NEUROLOGY |
2012 | Striatal dopamine loss and discriminative sensory dysfunction in Parkinson's disease | ACTA NEUROLOGICA SCANDINAVICA |
2017 | Subcortical 18 F-AV-1451 binding patterns in progressive supranuclear palsy | MOVEMENT DISORDERS |
2016 | Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis | JOURNAL OF ALZHEIMERS DISEASE |
2016 | Tau PET in Alzheimer disease and mild cognitive impairment | NEUROLOGY |
2018 | Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms
| JOURNAL OF MOVEMENT DISORDERS |
2020 | Temporal trajectories of in vivo tau and amyloid-β accumulation in Alzheimer's disease | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2022 | Temporal trajectory model for dopaminergic input to the striatal subregions in Parkinson's disease | PARKINSONISM & RELATED DISORDERS |
2011 | The effect of age on motor deficits and cerebral glucose metabolism of Parkinson's disease | ACTA NEUROLOGICA SCANDINAVICA |
2020 | The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease | JOURNAL OF ALZHEIMERS DISEASE |
2021 | The impact of demographic, clinical, genetic, and imaging variables on tau PET status
| EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2019 | THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report
| BMC NEUROLOGY |
2010 | Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. | MOVEMENT DISORDERS |